Literature DB >> 13761249

[Studies on electronoptic and immunomorphological structure of amyloid].

E LETTERER, R CAESAR, A VOGT.   

Abstract

Keywords:  AMYLOID SUBSTANCE

Mesh:

Substances:

Year:  1960        PMID: 13761249     DOI: 10.1055/s-0028-1112672

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  10 in total

1.  [On amyloid genesis].

Authors:  S BATTAGLIA
Journal:  Klin Wochenschr       Date:  1961-08-01

2.  [CLINICAL ASPECTS AND HISTOLOGY OF GENERALIZED SKIN-MUSCLE-PAR-AMYLOIDOSIS].

Authors:  F NOEDL; H ZAUN
Journal:  Arch Klin Exp Dermatol       Date:  1964-09-10

3.  [Lichen amyloidosus as example of pericollagenous, primary, skin limited and principally localized amyloidosis].

Authors:  W Schneider; H P Missmahl
Journal:  Arch Klin Exp Dermatol       Date:  1966-02-28

4.  Immunological characterization of amyloid fibrils in tissue sections.

Authors:  G Husby; J B Natvig
Journal:  Clin Exp Immunol       Date:  1972-07       Impact factor: 4.330

5.  Immunogenicity of amyloid.

Authors:  E S Cathcart; M Skinner; A S Cohen
Journal:  Immunology       Date:  1971-06       Impact factor: 7.397

6.  Importance of immune complex in transplantation.

Authors:  K Saito
Journal:  Jpn J Surg       Date:  1972-03

7.  Serum immunoconglutinin levels in human amyloidosis and myelomatosis.

Authors:  T J Muckle
Journal:  Ann Rheum Dis       Date:  1968-11       Impact factor: 19.103

Review 8.  [Endogenous storage diseases of the lung. Attempt at classification clinical diagnosis and problems].

Authors:  F J Bassermann
Journal:  Pneumonologie       Date:  1971

9.  Fine structure of the glomerulus in human and experimental renal amyloidosis.

Authors:  T Shirahama; A S Cohen
Journal:  Am J Pathol       Date:  1967-11       Impact factor: 4.307

10.  THE ISOLATION OF AMYLOID FIBRILS AND A STUDY OF THE EFFECT OF COLLAGENASE AND HYALURONIDASE.

Authors:  A S COHEN; E CALKINS
Journal:  J Cell Biol       Date:  1964-06       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.